Clinical Trials Logo

Chondrosarcoma clinical trials

View clinical trials related to Chondrosarcoma.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03670069 Terminated - Clinical trials for Metastatic Soft Tissue Sarcoma

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Start date: September 30, 2019
Phase: Phase 1
Study type: Interventional

This pilot phase I trial studies how well itacitinib works in treating patients with sarcomas that do not respond to treatment (refractory) and have spread to other parts of the body (advanced/metastatic). Itacitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT00543712 Terminated - Chondrosarcoma Clinical Trials

A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Start date: May 31, 2007
Phase: Phase 2
Study type: Interventional

This is a multicenter, open-label, Phase II trial designed to evaluate the efficacy and safety of PRO95780 when given as a single agent in patients with advanced chondrosarcoma. Up to 90 patients with confirmed chondrosarcoma will be enrolled.

NCT ID: NCT00003292 Terminated - Chondrosarcoma Clinical Trials

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Start date: July 1998
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ifosfamide in treating patients with meningeal tumors that have recurred or that cannot be removed surgically.